The Effect of Pomegranate (Punica Granatum L.) Peel Compress Application on Pain and Physical Function Status
NCT ID: NCT06034106
Last Updated: 2023-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
67 participants
INTERVENTIONAL
2023-04-14
2023-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Turmeric for Patients With Basal Joint Arthritis
NCT03017118
Yoga Versus Home Exercise Program in Children With Enthesitis Related Arthritis
NCT03858504
Investigation of Upper Extremity Functions in Patients With Rheumatoid Arthritis
NCT06767618
Distress in Rheumatoid Arthritis Patients
NCT06068920
Osteoarthritis in Terms of ICF Components
NCT04956510
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pomegranate (P. granatum) peel compress group
36 g of pomegranate peel powder was given to the patient in a closed container. A teaspoon (approximately 2-3 g) of powder was mixed with water from the storage container and applied to the patient's knee by making a paste, and then the knee was wrapped with a bandage. It was kept for 20 minutes by placing a hot thermophore (approximately 40-45 C) on it. This application was carried out 3 days a week.
Pomegranate (Punica granatum) peel compress
Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.
Hot compress
In the hot compress group, the knee was wrapped with a bandage and the hot thermophor (approximately 40-45 °C) was placed on the knee. The hot thermoform was applied to the patient 3 days a week by keeping it for 20 minutes.
Pomegranate (Punica granatum) peel compress
Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.
Hot compress
Hot compress was applied 3 days a week for 3 weeks.
Control Group
Patients in the control group did not receive any additional intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pomegranate (Punica granatum) peel compress
Pomegranate (Punica granatum) peel compress was applied 3 days a week for 3 weeks by turning the powder into porridge check.
Hot compress
Hot compress was applied 3 days a week for 3 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* those aged 45 and over,
* Diagnosed with knee OA by a physician according to the criteria of the American - Rheumatology Association (ARD),
* pain lasting at least 1 month or longer,
* not included in any physical therapy program during the research period, a
* capable of answering research questions,
* agreeing to participate in the research by giving verbal and written consent
Exclusion Criteria
* having vision and hearing problems,
* diagnosed with complex disease such as malignant,
* having a wound in the application area,
* with a diagnosed vascular disease,
* the patient's other inflammatory disease such as rheumatoid arthritis, gout, fibromyalgia
* who have had serious trauma or surgery in the last 6 months,
* who have received DMARDS or intra-articular steroid injection therapy in the last 3 months
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TC Erciyes University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dilek Efe Arslan
ErciyesU
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DİLEK EFE ARSLAN
Role: STUDY_DIRECTOR
ERCİYES UNİVERSİTY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dilek Efe Arslan
Kayseri, Melikgazi, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
getat51
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.